Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Fukang Pharmaceutical is a Chinese pharmaceutical company based in Meihekou, Jilin Province, and operates as a key subsidiary of the Xiuzheng Pharmaceutical Group. The company specializes in the research, development, and large-scale manufacturing of both chemical drugs and Traditional Chinese Medicine (TCM) preparations. Its product portfolio primarily focuses on cardiovascular and cerebrovascular health, featuring flagship products like Xinnao Shuantong capsules. Jilin Fukang maintains modern GMP-certified production facilities for various dosage forms, including capsules, tablets, and granules. The company plays a significant role in the regional pharmaceutical industry, contributing to the broader healthcare offerings of its parent conglomerate.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 吉林福康药业.